APPB — Applied Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Applied Biosciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.017 | -0.028 | -0.516 | -2.39 | -2.68 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | — | 0.376 | 1.5 | 1.48 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.002 | -0.002 | -0.031 | -0.013 | 0.257 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.015 | -0.03 | -0.151 | -0.673 | -0.905 |
| Capital Expenditures | — | — | -0.475 | -0.005 | -0.002 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0 | -0.3 | -0.169 | -0.712 |
| Acquisition of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | -0.775 | -0.173 | -0.713 |
| Financing Cash Flow Items | 0.01 | 0.029 | — | -0.1 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.01 | 0.032 | 1.14 | 0.695 | 1.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.005 | 0.002 | 0.213 | -0.152 | -0.014 |